InvestorsHub Logo
Followers 114
Posts 17294
Boards Moderated 1
Alias Born 09/12/2005

Re: None

Tuesday, 03/08/2022 1:04:55 PM

Tuesday, March 08, 2022 1:04:55 PM

Post# of 26272
William A. Hartman, Chairman, President & CEO of Halberd Corporation, stated, "We have a tremendous team of experts, and with the addition of Dr. Cooper, we will expand our technical capabilities. Dr. Cooper heads up a well-equipped laboratory at YSU which has been an invaluable technical resource in our R&D accomplishments to date. In addition to the neurodegenerative disease program at Halberd, Dr. Cooper will also focus his efforts on the microbiology associated with the eradication of E. Coli and bacterial infections using lasers and/or radio frequency exposure in our patented extracorporeal process."